NASDAQ:URGN

Urogen Pharma Stock Predictions

etoro logo Buy URGN
*Your capital is at risk
$26.60
+0.0600 (+0.226%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

URGN Prediction Chart

URGN Predictions History

Latest community submissions for URGN.
Predictor Target Session Target Price Result Direction Accuracy Score
May 29, 2025 Bullish $3.97 X 0
May 14, 2025 $10.51 +3.62% $9.87 X 93.55% 0
May 14, 2025 $10.37 +2.26% $9.87 X 94.94% 0
May 14, 2025 Bullish $9.87 X 0
Feb 3, 2025 Bearish $11.21 X 0
Aug 15, 2023 $21.94 -3.08% $22.36 V 98.13% 1
Aug 15, 2023 $22.20 -1.93% $22.36 V 99.30% 4
Aug 15, 2023 Bullish $22.36 X 0
May 3, 2019 $36.74 +1.02% $36.37 X 98.98% 1
May 2, 2019 $36.30 +0.28% $36.20 X 99.72% 4
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for URGN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT UROGEN PHARMA LTD
UroGen Pharma
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE